| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.IJID.2014.05.016 |
| P8608 | Fatcat ID | release_w2trtnsb35f75bnapnp5m6yrga |
| P932 | PMC publication ID | 4197066 |
| P698 | PubMed publication ID | 25172265 |
| P5875 | ResearchGate publication ID | 265169687 |
| P2093 | author name string | Yanping Chen | |
| Shan Chen | |||
| Junwei Li | |||
| Mingtao Zeng | |||
| Maria T Arévalo | |||
| P2860 | cites work | Protective immunity against tularemia provided by an adenovirus-vectored vaccine expressing Tul4 of Francisella tularensis | Q35805265 |
| Immune CD4+ T cells promote the clearance of influenza virus from major histocompatibility complex class II -/- respiratory epithelium | Q35855596 | ||
| Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms | Q36129141 | ||
| H1N1 swine origin influenza infection in the United States and Europe in 2009 may be similar to H1N1 seasonal influenza infection in two Australian states in 2007 and 2008. | Q36252862 | ||
| An overlapping protein-coding region in influenza A virus segment 3 modulates the host response | Q36554219 | ||
| Engineering influenza viral vectors | Q36591871 | ||
| An influenza A vaccine based on tetrameric ectodomain of matrix protein 2. | Q36727331 | ||
| A complicated message: Identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. | Q37275127 | ||
| Flu: no sign so far that the human pandemic is spread by pigs | Q43533941 | ||
| Potential T cell epitopes within swine-origin triple reassortant influenza A (H3N2) variant virus which emerged in 2011: an immunoinformatics study | Q45355632 | ||
| Comparison of hemagglutination inhibition assay, an ELISA-based micro-neutralization assay and colorimetric microneutralization assay to detect antibody responses to vaccination against influenza A H1N1 2009 virus | Q45370615 | ||
| Uneven distribution of MHC class II epitopes within the influenza virus | Q45424153 | ||
| Evidence of an absence: the genetic origins of the 1918 pandemic influenza virus | Q45561981 | ||
| CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. | Q45756742 | ||
| An adenoviral vector-based mucosal vaccine is effective in protection against botulism | Q45882317 | ||
| [Etiology of hand-foot-and-mouth disease and genetic characteristics of Coxsackievirus A16 in Beijing, 2009]. | Q54386394 | ||
| CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch | Q80142432 | ||
| Lessons from pandemic influenza A(H1N1): The research-based vaccine industry's perspective | Q22251431 | ||
| Influenza pandemics of the 20th century | Q22305643 | ||
| Rapid cloning of high-affinity human monoclonal antibodies against influenza virus | Q24644672 | ||
| Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates | Q27348520 | ||
| Cross-reactive CD8 + T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses | Q27663289 | ||
| Influenza: lessons from past pandemics, warnings from current incidents. | Q30351160 | ||
| Cell-mediated protection in influenza infection. | Q30353071 | ||
| Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. | Q30380173 | ||
| Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. | Q30380575 | ||
| Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. | Q30383723 | ||
| Assessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virus | Q30384376 | ||
| Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. | Q30385271 | ||
| Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus | Q30388401 | ||
| Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus. | Q30390815 | ||
| Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus | Q30395264 | ||
| T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model | Q30395346 | ||
| Development and characterization of a highly specific and sensitive SYBR green reverse transcriptase PCR assay for detection of the 2009 pandemic H1N1 influenza virus on the basis of sequence signatures | Q30396354 | ||
| Seasonal FluMist vaccination induces cross-reactive T cell immunity against H1N1 (2009) influenza and secondary bacterial infections | Q30397441 | ||
| Serologic survey on pandemic influenza A (H1N1) virus among aged ≥ 3 years population from Jiangsu province in 2009, China | Q30397527 | ||
| Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine | Q30398068 | ||
| Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets | Q30398516 | ||
| Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells | Q30403572 | ||
| Cross-neutralizing antibodies to pandemic 2009 H1N1 and recent seasonal H1N1 influenza A strains influenced by a mutation in hemagglutinin subunit 2. | Q30404095 | ||
| Influenza A viruses: new research developments | Q30404670 | ||
| Seasonal H1N1 influenza virus infection induces cross-protective pandemic H1N1 virus immunity through a CD8-independent, B cell-dependent mechanism | Q30410126 | ||
| Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans | Q30412301 | ||
| A distinct lineage of influenza A virus from bats | Q30413578 | ||
| Seasonal trivalent inactivated influenza vaccine protects against 1918 Spanish influenza virus infection in ferrets | Q30416288 | ||
| CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection | Q30416762 | ||
| A human CD4+ T cell epitope in the influenza hemagglutinin is cross-reactive to influenza A virus subtypes and to influenza B virus | Q30418319 | ||
| A "universal" human influenza A vaccine | Q34323032 | ||
| Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children | Q35167127 | ||
| P921 | main subject | influenza vaccine | Q383260 |
| attenuated vaccine | Q1810913 | ||
| P304 | page(s) | 37-43 | |
| P577 | publication date | 2014-08-27 | |
| P1433 | published in | International Journal of Infectious Diseases | Q15262334 |
| P1476 | title | T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine | |
| P478 | volume | 27 |
| Q63246270 | Advances in mRNA Vaccines for Infectious Diseases |
| Q30380824 | Comparative study of lymphocytes from individuals that were vaccinated and unvaccinated against the pandemic 2009-2011 H1N1 influenza virus in Southern Brazil. |
| Q47563687 | Conventional influenza vaccines influence the performance of a universal influenza vaccine in mice |
| Q47105096 | Efficacy of an Adenoviral Vectored Multivalent Centralized Influenza Vaccine. |
| Q56880026 | Extending the Breadth of Influenza Vaccines: Status and Prospects for a Universal Vaccine |
| Q54247364 | Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine. |
| Q54227564 | Heterosubtypic immunity increases infectious dose required to infect Mallard ducks with Influenza A virus. |
| Q35507796 | Intranasal vaccination with an engineered influenza virus expressing the receptor binding subdomain of botulinum neurotoxin provides protective immunity against botulism and influenza |
| Q37311543 | Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) Viruses among Children and Adolescents following 2014-2015 Inactivated and Live Attenuated Influenza Vaccination |
| Q30381595 | Refining the approach to vaccines against influenza A viruses with pandemic potential. |
| Q90747724 | Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution? |
| Q92000490 | Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution? |
| Q37123679 | Vaccine-generated lung tissue-resident memory T cells provide heterosubtypic protection to influenza infection |
Search more.